Hainan Shuangcheng Pharmaceuticals (002693.SZ): Production license of Ningbo Shuangcheng Pharmaceuticals changed, involving an increase in entrusted production information.

Gelonghui Finance · Jun 20 06:12

Gelonghui, June 20, 丨 Shuangcheng Pharmaceutical (002693.SZ) announced that the company's holding subsidiary, Ningbo Shuangcheng Pharmaceutical Co., Ltd. (“Ningbo Shuangcheng”), recently obtained a “Pharmaceutical Production License” issued by the Zhejiang Drug Administration. The matters involved in this change are: it was agreed that Ningbo Shuangcheng will add the name of the trustee company to the entrustment or fiduciary situation as Zhejiang Heze Pharmaceutical Technology Co., Ltd., the production/registration address is Room 201, Building 4, No. 101, Xiasha Street, Qiantang District, Hangzhou, Zhejiang Province. The drug name is KY-XES, there is no approval number, and the contract is valid until November 13, 2027. Other content remains unchanged.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

双成药业(002693.SZ)：宁波双成药品生产许可证变更 涉及受托生产信息的增加

Hainan Shuangcheng Pharmaceuticals (002693.SZ): Production license of Ningbo Shuangcheng Pharmaceuticals changed, involving an increase in entrusted production information.

Risk Disclaimer

Statement

双成药业(002693.SZ)：宁波双成药品生产许可证变更涉及受托生产信息的增加